Invasive disease-free and overall survival after (neo)adjuvant chemotherapy in postmenopausal patients with hormone receptor-positive, HER2-negative early breast cancer treated with upfront letrozole: Experiences from the phase IV PreFace trial
绝经后激素受体阳性、HER2阴性早期乳腺癌患者接受一线来曲唑治疗后，在（新）辅助化疗后的无侵袭性疾病生存期和总生存期：来自IV期PreFace试验的经验
期刊:International Journal of Cancer
影响因子:4.7
doi:10.1002/ijc.70037
Beierlein, Milena; Häberle, Lothar; Nabieva, Naiba; Maass, Nicolai; Aktas, Bahriye; Kümmel, Sherko; Thomssen, Christoph; Wolf, Christopher; Kolberg, Hans-Christian; Brucker, Cosima; Janni, Wolfgang; Dall, Peter; Schneeweiss, Andreas; Marme, Frederik; Sütterlin, Marc W; Ruebner, Matthias; Theuser, Anna-Katharin; Hofmann, Nadine M; Böhm, Sybille; Almstedt, Katrin; Kellner, Sara; Gass, Paul; Lück, Hans-Joachim; Hein, Alexander; Schmatloch, Sabine; Kalder, Matthias; Uleer, Christoph; Juhasz-Böss, Ingolf; Hanf, Volker; Jackisch, Christian; Müller, Volkmar; Rack, Brigitte; Belleville, Erik; Wallwiener, Diethelm; Rody, Achim; Rauh, Claudia; Bayer, Chistian M; Uhrig, Sabrina; Huebner, Hanna; Goossens, Chloë; Brucker, Sara Y; Hack, Carolin C; Fehm, Tanja N; Fasching, Peter A
